Free tool
Stocks listed on Nasdaq GS
We cover 296 companies listed on Nasdaq GS. The median market value in the group is $1.53B. Across the group, the median move over the past trading day is −0.39%. 69% of the 280 with a 200-day average trade above it. Price change over the past year runs from −36.4% to +195.4% across the middle 80 percent of the group, with a median of +29.5%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
296 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −21.38% |
| SNY | Sanofi | $108.83B | Large cap | −4.33% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| MRNA | Moderna, Inc. | $59.75B | Large cap | +496.25% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| MDLN | Medline Inc. | $46.53B | Large cap | −13.07% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% |
| IDXX | IDEXX Laboratories, Inc. | $43.66B | Large cap | −13.64% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% |
| BNTX | BioNTech SE | $28.28B | Large cap | +9.27% |
| INSM | Insmed Incorporated | $27.16B | Large cap | −7.54% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% |
| MEDP | Medpace Holdings, Inc. | $17.28B | Large cap | +30.74% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +100.35% |
| ASND | Ascendis Pharma A/S | $16.41B | Large cap | +29.66% |
| NBIX | Neurocrine Biosciences, Inc. | $15.92B | Large cap | +13.36% |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | +60.05% |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −1.93% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% |
| ICLR | ICON Public Limited Company | $13.03B | Large cap | −2.91% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | +11.85% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +308.99% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.45B | Large cap | +26.78% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +156.37% |
| ALGN | Align Technology, Inc. | $11.31B | Large cap | +12.09% |
| CYTK | Cytokinetics, Incorporated | $11.01B | Large cap | +109.36% |
| KRYS | Krystal Biotech, Inc. | $10.65B | Large cap | +143.67% |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +48.21% |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.01% |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| PODD | Insulet Corporation | $9.94B | Mid cap | −57.12% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +99.97% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| BRKR | Bruker Corporation | $8.69B | Mid cap | +70.56% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| ALKS | Alkermes plc | $8.25B | Mid cap | +68.07% |
| SYRE | Spyre Therapeutics, Inc. | $8.13B | Mid cap | +446.12% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +1112.03% |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +196.85% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.27B | Mid cap | +92.20% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $6.07B | Mid cap | +46.02% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.05B | Mid cap | +133.47% |
| DFTX | Definium Therapeutics, Inc. | $5.88B | Mid cap | +344.37% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +5.41% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| GRFS | Grifols, S.A. | $5.38B | Mid cap | −19.39% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +207.13% |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +121.31% |
| WAY | Waystar Holding Corp. | $4.63B | Mid cap | −34.97% |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% |
| ICUI | ICU Medical, Inc. | $4.49B | Mid cap | +41.83% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| LIVN | LivaNova PLC | $4.41B | Mid cap | +41.56% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.23B | Mid cap | +47.06% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| IRTC | iRhythm Holdings, Inc. | $4.06B | Mid cap | −29.83% |
| LEGN | Legend Biotech Corporation | $4.02B | Mid cap | −40.44% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +57.50% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| TLX | Telix Pharmaceuticals Limited | $3.77B | Mid cap | −8.02% |
| OPCH | Option Care Health, Inc. | $3.60B | Mid cap | −15.91% |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% |
| QURE | uniQure N.V. | $3.53B | Mid cap | +223.49% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| MBX | MBX Biosciences, Inc. | $3.22B | Mid cap | +366.53% |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +79.06% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +60.64% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.10B | Mid cap | +22.19% |
| ALMS | Alumis Inc. | $3.06B | Mid cap | +380.08% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ALHC | Alignment Healthcare, Inc. | $2.88B | Mid cap | −13.88% |
| ACHC | Acadia Healthcare Company, Inc. | $2.85B | Mid cap | +37.81% |
| PRVA | Privia Health Group, Inc. | $2.71B | Mid cap | −3.13% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −12.10% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +15.38% |
| KLRA | Kailera Therapeutics, Inc. | $2.39B | Mid cap | −29.08% |
| ALMR | Alamar Biosciences, Inc. | $2.36B | Mid cap | +54.91% |
| COAG | Hemab Therapeutics Holdings, Inc. | $2.30B | Mid cap | +44.68% |
| MLYS | Mineralys Therapeutics, Inc. | $2.28B | Mid cap | +70.22% |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +57.99% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +4.47% |
| XRAY | DENTSPLY SIRONA Inc. | $2.18B | Mid cap | −21.61% |
| ZBIO | Zenas BioPharma, Inc. | $2.15B | Mid cap | +97.73% |
| HCM | HUTCHMED (China) Limited | $2.15B | Mid cap | −17.45% |
| STOK | Stoke Therapeutics, Inc. | $2.14B | Mid cap | +71.45% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| NVCR | NovoCure Limited | $2.08B | Mid cap | +50.21% |
| GENB | Generate Biomedicines, Inc. | $2.07B | Mid cap | +27.59% |
| SRPT | Sarepta Therapeutics, Inc. | $2.06B | Mid cap | +7.69% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $2.03B | Mid cap | −13.45% |
| CMPS | COMPASS Pathways plc | $2.02B | Mid cap | +209.53% |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% |
| LKFT | Lakefront Biotherapeutics NV | $1.91B | Small cap | −11.39% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −38.48% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +326.47% |
| AVLN | Avalyn Pharma Inc. | $1.64B | Small cap | +25.60% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% |
| KMTS | Kestra Medical Technologies, Ltd. | $1.56B | Small cap | +47.61% |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.06% |
| OMCL | Omnicell, Inc. | $1.53B | Small cap | +0.66% |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| SPTX | Seaport Therapeutics, Inc. | $1.49B | Small cap | +40.32% |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +178.79% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| AKTS | Aktis Oncology, Inc. | $1.47B | Small cap | +18.35% |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% |
| PNTG | The Pennant Group, Inc. | $1.34B | Small cap | +56.31% |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% |
| GDRX | GoodRx Holdings, Inc. | $1.25B | Small cap | −18.89% |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% |
| SVRA | Savara Inc. | $1.15B | Small cap | +70.52% |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.15B | Small cap | −35.42% |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +6.34% |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% |
| DSGN | Design Therapeutics, Inc. | $975.65M | Small cap | +194.71% |
| BVS | Bioventus Inc. | $954.22M | Small cap | +86.52% |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $934.98M | Small cap | −27.78% |
| ACRS | Aclaris Therapeutics, Inc. | $911.16M | Small cap | +240.11% |
| CBLL | CeriBell, Inc. | $899.97M | Small cap | +102.16% |
| SGP | SpyGlass Pharma, Inc. | $891.05M | Small cap | +0.91% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% |
| INMD | InMode Ltd. | $864.89M | Small cap | −1.71% |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% |
| COLL | Collegium Pharmaceutical, Inc. | $852.79M | Small cap | −29.08% |
| HSTM | HealthStream, Inc. | $840.94M | Small cap | +1.86% |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +690.00% |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% |
| ASMB | Assembly Biosciences, Inc. | $721.17M | Small cap | +36.81% |
| PHAT | Phathom Pharmaceuticals, Inc. | $709.50M | Small cap | −29.50% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $708.88M | Small cap | +240.48% |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% |
| AGMB | AgomAb Therapeutics NV | $703.26M | Small cap | −2.53% |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% |
| EVO | Evotec SE | $693.01M | Small cap | −44.13% |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −20.13% |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% |
| VALN | Valneva SE | $634.84M | Small cap | −23.49% |
| AUTL | Autolus Therapeutics plc | $620.16M | Small cap | +48.41% |
| ARVN | Arvinas, Inc. | $609.40M | Small cap | +15.35% |
| MPLT | MapLight Therapeutics, Inc. | $596.42M | Small cap | −29.88% |
| CTKB | Cytek Biosciences, Inc. | $594.02M | Small cap | +11.74% |
| RGNX | REGENXBIO Inc. | $588.18M | Small cap | +6.35% |
| KYTX | Kyverna Therapeutics, Inc. | $546.70M | Small cap | +133.33% |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +116.67% |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +0.43% |
| CGC | Canopy Growth Corporation | $492.21M | Small cap | −31.46% |
| EDIT | Editas Medicine, Inc. | $488.38M | Small cap | +19.10% |
| NRC | NRC Health | $487.06M | Small cap | +45.92% |
| PACB | Pacific Biosciences of California, Inc. | $484.90M | Small cap | +17.29% |
| KMDA | Kamada Ltd. Ordinary Shares | $483.48M | Small cap | +21.09% |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% |
| PRTA | Prothena Corporation plc | $474.87M | Small cap | +8.06% |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.87% |
| BIOA | BioAge Labs, Inc. | $451.63M | Small cap | +107.59% |
| AVIR | Atea Pharmaceuticals, Inc. | $441.93M | Small cap | +53.06% |
| CARL | Carlsmed, Inc. | $441.76M | Small cap | +16.40% |
| CCRN | Cross Country Healthcare Inc | $428.06M | Small cap | +0.38% |
| ENTA | Enanta Pharmaceuticals, Inc. | $412.12M | Small cap | +65.89% |
| OFIX | Orthofix Medical Inc. | $397.14M | Small cap | −34.30% |
| UPB | Upstream Bio, Inc. | $390.52M | Small cap | −57.31% |
| MOBI | Mobia Medical, Inc. | $387.35M | Small cap | −0.85% |
| SLP | Simulations Plus, Inc. | $372.34M | Small cap | +28.20% |
| LYEL | Lyell Immunopharma, Inc. | $362.68M | Small cap | +37.32% |
| IFRX | InflaRx N.V. | $356.63M | Small cap | +142.00% |
| TMCI | Treace Medical Concepts, Inc. | $306.96M | Small cap | −36.39% |
| BCYC | Bicycle Therapeutics plc | $304.03M | Small cap | −37.79% |
| AVXL | Anavex Life Sciences Corp. | $300.34M | Small cap | −65.71% |
| MYGN | Myriad Genetics, Inc. | $298.43M | Small cap | −47.39% |
| NMRA | Neumora Therapeutics, Inc. | $293.12M | Small cap | −11.36% |
| ANIK | Anika Therapeutics, Inc. | $290.14M | Small cap | +136.17% |
| EMBC | Embecta Corp. | $285.00M | Small cap | −64.70% |
| PYXS | Pyxis Oncology, Inc. | $278.58M | Small cap | +145.59% |
| ALXO | ALX Oncology Holdings Inc. | $273.79M | Small cap | +65.00% |
| ALEC | Alector, Inc. | $263.51M | Small cap | +2.50% |
| MGNX | MacroGenics, Inc. Common Stock | $257.35M | Small cap | +134.88% |
| OSUR | OraSure Technologies, Inc. | $255.87M | Small cap | +11.08% |
| LAB | Standard BioTools Inc. | $255.18M | Small cap | −49.08% |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +2.86% |
| PEPG | PepGen Inc. | $237.21M | Small cap | +159.68% |
| RNA | Prosensa Holding B.V. Ordinary Shares | $236.91M | Small cap | −6.10% |
| TNXP | Tonix Pharmaceuticals Holding Corp. Common Stock | $233.94M | Small cap | −57.61% |
| UTMD | Utah Medical Products, Inc. | $225.70M | Small cap | +17.76% |
| SPOK | Spok Holdings, Inc. | $217.86M | Small cap | −36.39% |
| ABOS | Acumen Pharmaceuticals, Inc. | $216.23M | Small cap | +115.11% |
| VYGR | Voyager Therapeutics, Inc. | $213.20M | Small cap | +1.17% |
| ANTX | AN2 Therapeutics, Inc. | $208.68M | Small cap | +385.09% |
| NKTX | Nkarta, Inc. | $194.10M | Small cap | +17.41% |
| HUMA | Humacyte, Inc. | $189.35M | Small cap | −55.45% |
| CDXS | Codexis, Inc. | $180.68M | Small cap | −38.20% |
| OGI | Organigram Global Inc. | $177.67M | Small cap | −24.55% |
| LFCR | Lifecore Biomedical, Inc. | $176.02M | Small cap | −38.25% |
| MOLN | Molecular Partners AG | $170.46M | Small cap | +18.67% |
| AARD | Aardvark Therapeutics, Inc. | $149.04M | Small cap | −24.25% |
| INGN | Inogen, Inc. | $147.55M | Small cap | −29.89% |
| MIST | Milestone Pharmaceuticals Inc. | $146.91M | Small cap | −33.33% |
| LENZ | LENZ Therapeutics, Inc. | $146.73M | Small cap | −87.21% |
| MXCT | MaxCyte, Inc. | $139.33M | Small cap | −6.43% |
| BDTX | Black Diamond Therapeutics, Inc. | $130.42M | Small cap | −20.91% |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% |
| APYX | Apyx Medical Corporation | $128.48M | Small cap | +54.04% |
| BMEA | Biomea Fusion, Inc. | $123.95M | Small cap | −8.06% |
| HCAT | Health Catalyst, Inc. | $118.91M | Small cap | −56.91% |
| SEER | Seer, Inc. | $112.96M | Small cap | −1.94% |
| LUNG | Pulmonx Corporation | $105.59M | Small cap | +34.41% |
| ATRA | Atara Biotherapeutics, Inc. | $94.15M | Micro cap | −24.05% |
| CVRX | CVRx, Inc. | $87.12M | Micro cap | −56.75% |
| GOSS | Gossamer Bio, Inc. | $85.01M | Micro cap | −92.93% |
| DH | Definitive Healthcare Corp. | $84.34M | Micro cap | −80.44% |
| OM | Outset Medical, Inc. | $79.89M | Micro cap | −69.56% |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −31.36% |
| SPRO | Spero Therapeutics, Inc. | $71.05M | Micro cap | −38.38% |
| XBIT | XBiotech Inc. | $70.43M | Micro cap | −33.62% |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% |
| BOLD | Boundless Bio, Inc. | $66.31M | Micro cap | +155.70% |
| MCRB | Seres Therapeutics, Inc. | $47.81M | Micro cap | −74.79% |
| MGX | Metagenomi Therapeutics, Inc. | $46.09M | Micro cap | −34.41% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $44.46M | Micro cap | −74.90% |
| PETS | PetMed Express, Inc. | $38.81M | Micro cap | −43.35% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% |
| NXTC | NextCure, Inc. | $27.05M | Micro cap | +11.37% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
| TRIB | Trinity Biotech plc | $7.80M | Micro cap | +547.97% |
| BTSGU | BrightSpring Health Services, Inc. | — | — | +142.79% |
| CRBU | Caribou Biosciences, Inc. | — | — | −16.67% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.